Your search returned 4 results.

Sort
Results
1.
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial. MedStar authors:
  • Brewer, H Bryan
PMID:
  • 26385396
Year: 2016
Citation:
  • American Journal of Cardiovascular Drugs. 16(1):55-65, 2016 Feb.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Clinical Trial, Phase II
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Ballantyne CM, Barter PJ, Borgman M, Brewer HB, Herrman JP, Hu B, Kastelein JJ, Kataoka Y, Merkely B, Nicholls SJ, Nissen SE, Puri R, Uno K, Wolski K
2.
Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial. MedStar authors:
  • Brewer, H Bryan
PMID:
  • 26047975
Year: 2015
Citation:
  • Lancet. 386(9992):452-60, 2015 Aug 1.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Clinical Trial, Phase II
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Barter PJ, Brewer HB, Ford J, Hovingh GK, Kastelein JJ, Rader DJ, Round P, Saleheen D, van Deventer SJ
3.
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease. MedStar authors:
  • Brewer, H Bryan
PMID:
  • 28514624
Year: 2017
Citation:
  • New England Journal of Medicine. 376(20):1933-1942, 2017 05 18
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • ACCELERATE Investigators, Barter PJ, Brewer HB, Conde D, Fox KAA, Gibson CM, Goodman SG, Granger C, Kandath D, Kouz S, Leiva-Pons JL, Li W, Lincoff AM, Mason D, McErlean E, McGuire DK, Menon V, Montalescot G, Nicholls SJ, Nicolau JC, Nissen SE, Pesant Y, Rader D, Riesmeyer JS, Ruotolo G, Tahirkheli N, Tall AR, Vangerow B, Weerakkody G, Wolski K
4.
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. MedStar authors:
  • Ratner, Robert E
PMID:
  • 23175674
Year: 2013
Citation:
  • Arteriosclerosis, Thrombosis & Vascular Biology. 33(2):393-9, 2013 Feb.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
Form of publication:
  • Journal Article
All authors:
  • Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Henry RR, Hodis HN, Kitabchi AE, Mack WJ, Mudaliar S, Musi N, Ratner RE, Reaven PD, Saremi A, Schwenke DC, Stentz FB, Tripathy D
Pages

Powered by Koha